Literature DB >> 9731473

Antitumour and radioprotective action of Podophyllum hexandrum.

H C Goel1, J Prasad, A Sharma, B Singh.   

Abstract

A significant antitumour effect of P. hexandrum, a herb thriving at Himalayas (2500-4000 m), was observed in strain 'A' mice carrying solid tumours developed by transplanting Ehrlich ascites tumour (EAT). Subtoxic well tolerated sequential doses of aqueous extract of P. hexandrum (a daily dose of 34.5 mg/kg b.w. for 15 days) enhanced tumour doubling time (TDT) from 1.94 +/- 0.26 days to 19.1 +/- 2.5 days. However, no synergism was revealed between radiation and P. hexandrum, though both independently manifested antitumour effects. In normal mice, pre-irradiation administration of extract of P. hexandrum protected mice in a dose dependent manner (optimal dose being 34.5 mg/kg body.wt. rendering 72% survival for 30 days) against whole body lethal irradiation of 10 Gy. Radioprotective properties of P. hexandrum were found to be comparable to synthetic radioprotectors like diltiazem etc.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9731473

Source DB:  PubMed          Journal:  Indian J Exp Biol        ISSN: 0019-5189            Impact factor:   0.818


  14 in total

1.  Podophyllum hexandrum modulates gamma radiation-induced immunosuppression in Balb/c mice: implications in radioprotection.

Authors:  H C Goel; H Prakash; A Ali; M Bala
Journal:  Mol Cell Biochem       Date:  2006-10-07       Impact factor: 3.396

2.  Evaluation of radioprotective activities Rhodiola imbricata Edgew--a high altitude plant.

Authors:  Rajesh Arora; Raman Chawla; Ravinder Sagar; Jagdish Prasad; Surendar Singh; Raj Kumar; Ashok Sharma; Shikha Singh; Rakesh Kumar Sharma
Journal:  Mol Cell Biochem       Date:  2005-05       Impact factor: 3.396

3.  Antioxidant activity of fractionated extracts of rhizomes of high-altitude Podophyllum hexandrum: role in radiation protection.

Authors:  Raman Chawla; Rajesh Arora; Raj Kumar; Ashok Sharma; Jagdish Prasad; Surendar Singh; Ravinder Sagar; Pankaj Chaudhary; Sandeep Shukla; Gurpreet Kaur; Rakesh Kumar Sharma; Satish Chander Puri; Kanaya Lal Dhar; Geeta Handa; Vinay Kumar Gupta; Ghulam Nabi Qazi
Journal:  Mol Cell Biochem       Date:  2005-05       Impact factor: 3.396

4.  Radioprotective properties of apple polyphenols: an in vitro study.

Authors:  Pankaj Chaudhary; Sandeep Kumar Shukla; I Prem Kumar; I Namita; Farhat Afrin; Rakesh Kumar Sharma
Journal:  Mol Cell Biochem       Date:  2006-03-15       Impact factor: 3.396

5.  Immunomodulatory and cytoprotective role of RP-1 in gamma-irradiated mice.

Authors:  H C Goel; P K Agrawala; V Pathania; N Malhotra
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

6.  Radiation protection of HepG2 cells by Podophyllum hexandrum Royale.

Authors:  Damodar Gupta; Rajesh Arora; Amar Prakash Garg; Harish Chandra Goel
Journal:  Mol Cell Biochem       Date:  2003-08       Impact factor: 3.396

7.  Production of podophyllotoxin from Podophyllum hexandrum: a potential natural product for clinically useful anticancer drugs.

Authors:  A Giri; M Lakshmi Narasu
Journal:  Cytotechnology       Date:  2000-10       Impact factor: 2.058

8.  Traditional herbal medicine in far-west Nepal: a pharmacological appraisal.

Authors:  Ripu M Kunwar; Keshab P Shrestha; Rainer W Bussmann
Journal:  J Ethnobiol Ethnomed       Date:  2010-12-13       Impact factor: 2.733

9.  Role of Apoptotic Proteins in REC-2006 Mediated Radiation Protection in Hepatoma Cell Lines.

Authors:  Pankaj Kumar Singh; Raj Kumar; Ashok Sharma; Rajesh Arora; Raman Chawla; Swatantra Kumar Jain; Rajendra Prasad Tripathi; Rakesh Kumar Sharma
Journal:  Evid Based Complement Alternat Med       Date:  2011-03-20       Impact factor: 2.629

10.  Podophyllum hexandrum-Mediated Survival Protection and Restoration of Other Cellular Injuries in Lethally Irradiated Mice.

Authors:  Sanghmitra Sankhwar; Manju Lata Gupta; Vanita Gupta; Savita Verma; Krishna Avtar Suri; Memita Devi; Punita Sharma; Ehsan Ahmed Khan; M Sarwar Alam
Journal:  Evid Based Complement Alternat Med       Date:  2011-02-13       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.